Synopsis
Synopsis
0
USDMF
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Acetorphan
2. Acetorphan, (r)-isomer
3. Acetorphan, (s)-isomer
4. Ecadotril
5. N-(3-acetylmercapto-2-benzylpropanoyl)glycine Benzyl Ester
6. Retorphan
7. Sinorphan
1. 81110-73-8
2. Acetorphan
3. Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate
4. Hidrasec
5. Tiorfan
6. Racecadotril [inn]
7. Tiorfix
8. S049; Sinorphan
9. Racecadotril (acetorphan)
10. Nsc-759828
11. 76k53xp4to
12. Benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate
13. Benzyl (3-(acetylthio)-2-benzylpropanoyl)glycinate
14. Racecadotril (inn)
15. Glycine, N-[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-,phenylmethyl Ester [cas]
16. Glycine, N-[(2r)-2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-, Phenylmethyl Ester
17. Smr000449320
18. Sr-01000759384
19. Racecadotril [inn:ban]
20. Unii-76k53xp4to
21. (+/-)-acetorphan
22. Benzyl 2-[[(2s)-2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate
23. 2-[[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino]acetic Acid (phenylmethyl) Ester
24. 2-{[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino}acetic Acid (phenylmethyl) Ester
25. Hidrasec (tn)
26. Prestwick_926
27. Racecadotril-[d5]
28. Tiorfan (tn)
29. Mfcd00865520
30. Cpd000449320
31. Prestwick0_000626
32. Prestwick1_000626
33. Prestwick2_000626
34. Prestwick3_000626
35. Racecadotril [mi]
36. Acetorphan [vandf]
37. (+-)-n-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)glycine Phenylmethyl Ester
38. Glycine, N-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, Phenylmethyl Ester
39. Glycine, N-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, Phenylmethyl Ester, (+-)-
40. Bspbio_000592
41. Racecadotril [mart.]
42. Mls000758279
43. Mls001423958
44. Mls006010032
45. Racecadotril [who-dd]
46. Schembl373243
47. Spbio_002811
48. Bpbio1_000652
49. Chembl2103772
50. Dtxsid8045513
51. Chebi:91508
52. Gtpl11654
53. Racecadotril, >=98% (hplc)
54. Hms1569n14
55. Hms2051k05
56. Hms2090l07
57. Hms2096n14
58. Hms2232f17
59. Hms3370b22
60. Hms3393k05
61. Hms3656c10
62. Hms3713n14
63. Hms3744i15
64. Hms3884f04
65. Pharmakon1600-01502331
66. Racecadotril [ep Monograph]
67. Bcp14746
68. Bcp22637
69. Racecadotril For Peak Identification
70. Bdbm50247884
71. Nsc759828
72. S2503
73. Akos015894948
74. Ab07493
75. Ac-1133
76. Ccg-100764
77. Ccg-213824
78. Cs-1127
79. Db11696
80. Hs-0029
81. Nc00014
82. Nsc 759828
83. (+-)-n-(alpha-(mercaptomethyl)hydrocinnamoyl)glycine, Benzyl Ester, Acetate (ester)
84. Ncgc00179511-01
85. Ncgc00179511-04
86. Br164305
87. Hy-17399
88. Sinorphan;bay Y 7432; Bay-y 7432
89. Db-015177
90. Ft-0602523
91. Ft-0700652
92. R0103
93. Sw197043-4
94. D08464
95. 110r738
96. A840045
97. Q416677
98. Sr-01000759384-4
99. Sr-01000759384-5
100. Benzyl N-[3-(acetylthio)-2-benzylpropionyl]glycinate
101. Brd-a08187463-001-03-8
102. N-[3-acetylthio-2-benzylpropanoyl]glycine Benzyl Ester
103. N-[3-(acetylthio)-2-benzylpropionyl]glycine Benzyl Ester
104. Racecadotril, European Pharmacopoeia (ep) Reference Standard
105. N-((r,s)-3-acetylthio-2-benzylpropanoyl)glycine Benzyl Ester
106. (2-acetylsulfanylmethyl-3-phenyl-propionylamino)-acetic Acid Benzyl Ester
107. Benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenyl-propanoyl]amino]acetate;racecadotril
108. Racecadotril For Peak Identification, European Pharmacopoeia (ep) Reference Standard
109. (+/-)-n-(.alpha.-(mercaptomethyl)hydrocinnamoyl)glycine, Benzyl Ester, Acetate (ester)
| Molecular Weight | 385.5 g/mol |
|---|---|
| Molecular Formula | C21H23NO4S |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 11 |
| Exact Mass | 385.13477939 g/mol |
| Monoisotopic Mass | 385.13477939 g/mol |
| Topological Polar Surface Area | 97.8 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 485 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidiarrheals
Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (See all compounds classified as Antidiarrheals.)
Protease Inhibitors
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)
A - Alimentary tract and metabolism
A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents
A07X - Other antidiarrheals
A07XA - Other antidiarrheals
A07XA04 - Racecadotril
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
87
PharmaCompass offers a list of Racecadotril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Racecadotril manufacturer or Racecadotril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Racecadotril manufacturer or Racecadotril supplier.
PharmaCompass also assists you with knowing the Racecadotril API Price utilized in the formulation of products. Racecadotril API Price is not always fixed or binding as the Racecadotril Price is obtained through a variety of data sources. The Racecadotril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A REDOTIL manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of REDOTIL, including repackagers and relabelers. The FDA regulates REDOTIL manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. REDOTIL API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of REDOTIL manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A REDOTIL supplier is an individual or a company that provides REDOTIL active pharmaceutical ingredient (API) or REDOTIL finished formulations upon request. The REDOTIL suppliers may include REDOTIL API manufacturers, exporters, distributors and traders.
click here to find a list of REDOTIL suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a REDOTIL Drug Master File in Korea (REDOTIL KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of REDOTIL. The MFDS reviews the REDOTIL KDMF as part of the drug registration process and uses the information provided in the REDOTIL KDMF to evaluate the safety and efficacy of the drug.
After submitting a REDOTIL KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their REDOTIL API can apply through the Korea Drug Master File (KDMF).
click here to find a list of REDOTIL suppliers with KDMF on PharmaCompass.
A REDOTIL CEP of the European Pharmacopoeia monograph is often referred to as a REDOTIL Certificate of Suitability (COS). The purpose of a REDOTIL CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of REDOTIL EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of REDOTIL to their clients by showing that a REDOTIL CEP has been issued for it. The manufacturer submits a REDOTIL CEP (COS) as part of the market authorization procedure, and it takes on the role of a REDOTIL CEP holder for the record. Additionally, the data presented in the REDOTIL CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the REDOTIL DMF.
A REDOTIL CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. REDOTIL CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of REDOTIL suppliers with CEP (COS) on PharmaCompass.
A REDOTIL written confirmation (REDOTIL WC) is an official document issued by a regulatory agency to a REDOTIL manufacturer, verifying that the manufacturing facility of a REDOTIL active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting REDOTIL APIs or REDOTIL finished pharmaceutical products to another nation, regulatory agencies frequently require a REDOTIL WC (written confirmation) as part of the regulatory process.
click here to find a list of REDOTIL suppliers with Written Confirmation (WC) on PharmaCompass.
REDOTIL Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of REDOTIL GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right REDOTIL GMP manufacturer or REDOTIL GMP API supplier for your needs.
A REDOTIL CoA (Certificate of Analysis) is a formal document that attests to REDOTIL's compliance with REDOTIL specifications and serves as a tool for batch-level quality control.
REDOTIL CoA mostly includes findings from lab analyses of a specific batch. For each REDOTIL CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
REDOTIL may be tested according to a variety of international standards, such as European Pharmacopoeia (REDOTIL EP), REDOTIL JP (Japanese Pharmacopeia) and the US Pharmacopoeia (REDOTIL USP).
